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The increasing incidence of type 2 diabetes and associated
morbidity poses an enormous challenge for public health.
The implementation of prevention programmes directed
towards individuals at high risk might reduce overall
morbidity and thus the cost to the healthcare system [1].
A large benefit in this regard might be achieved by
targeting south Asian immigrant populations living in
Europe, since various reports have suggested that these
populations not only have an increased risk of type 2
diabetes, but are also more likely to have other cardiovas-
cular risk factors [2–5]. In addition, type 2 diabetic patients
of south Asian origin are at a higher risk than white
populations of developing diabetes-related morbidity [6–8].
While immigrants of south Asian origin are thus an
important target group for active screening and preventive
interventions, data on the feasibility and effectiveness of
prevention programmes in these populations are scarce.
Issues that need to be explored include strategies to
promote the uptake of screening, the prevalence of
undetected diabetes mellitus and other metabolic risk
factors in various settings, the risk of morbidity associated
with undetected disease, and targeted preventive interven-
tions and their potential effectiveness in the south Asian
groups as compared with the white population. The study
by Webb et al. in this issue of Diabetologia [9], reports on
the results of one of the few ongoing studies in Europe to
address some of these different aspects [10–13]. This study
is based on data from the UK-based Leicester arm of the
Anglo–Danish–Dutch study of Intensive Treatment In
peOple with screeN detected diabetes in primary care
(ADDITION-Leicester) and focuses on white Europeans
and on south Asians who were predominantly of Indian
origin [10].
In this study, the response to an invitation for screening
by OGTT through community practices appeared to be
lower among the south Asian population than among the
white European population (13% vs 26%), despite the
employment of culturally sensitive promotional activities.
The odds of undetected type 2 diabetes or impaired glucose
regulation was twice as high among the screened south
Asians as among the white Europeans (2.30 [95% CI 1.68,
3.16] for type 2 diabetes and 2.08 [95% CI 1.38, 3.14] for
impaired glucose tolerance and impaired fasting glucose
[age- and sex-adjusted]). In addition, Webb et al. confirmed
the high cardiovascular burden among participants with
screen-detected type 2 diabetes or impaired glucose
regulation, and modelled the absolute risk reduction that
would be achieved by a preventive approach consisting of
the prescription of therapies targeting glycaemia, blood
pressure and cholesterol. The potential health gain appeared
to be substantial, particularly among the south Asian
population; this applied not only to those with type 2
diabetes, but also to those with impaired glucose regulation.
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base for type 2 diabetes screening. It clearly illustrates the
potential public health impact among south Asian immi-
grant populations. However, several issues have to be taken
into account when interpreting the estimated health gain.
First, those who did participate might be a relatively
healthy or health conscious subset of the south Asian
population, the so-called worried well. For example, in
contrast to the higher prevalence of overweight and central
obesity in south Asians compared with Europeans as
observed in a previous study (with overweight defined as
BMI ≥23 kg/m
2 for the south Asian population, and BMI
≥25 kg/m
2 for the Europeans) [14], the participants of south
Asian origin in the study of Webb et al. appeared relatively
healthy as they had a lower waist circumference than the
participants of white European origin. On the other hand,
medication use for other cardiovascular risk factors was
already higher among south Asian participants during the
screening than among white Europeans [9]. Without data on
those who did not participate, it is difficult to establish the
presence and direction of the possible bias owing to
selective participation.
Second, type 2 diabetes among south Asian populations,
in general, seem to occur earlier than in European
populations, as is illustrated by the relatively higher
prevalence in younger age groups [5]. While the
ADDITION-Leicester study applied a lower age range for
the south Asian population (25 years or older instead of
40 years), the younger age group was excluded from the
analyses [9]. Including younger age groups in screening
programmes may further increase the impact.
Third, it could be questioned whether the ETHRISK
calculator, used to estimate the 10 year cardiovascular risk,
accurately reflects the burden of disease in south Asian
populations. Although the ETHRISK equation was cali-
brated using register-based data, the equation has not been
validated because of a lack of prospective data among south
Asians [15]. The currently reported estimates reflect differ-
ences in the baseline risk and the distribution of risk factors
between populations, but perhaps not the possible differ-
ences in the 10 year cardiovascular risk associated with a
certain risk factor between populations. These differences
are not unlikely as reports have, for instance, suggested
differences in the risk of developing diabetes-related
morbidity between persons of south Asian and European
origin [7]. This could greatly affect the estimations of the
potential risk reduction that can be achieved. Without
adequate prospective data, it is difficult to determine
whether the estimations as given by Webb et al. are a
correct reflection or an under- or overestimation of the
actual burden of disease.
Although, according to these findings, the potential
health gain of screening for type 2 diabetes among south
Asian populations seems enormous, the study of Webb et al.
also raises a number of important points regarding the
optimal design for such a screening programme. These
points should be taken into consideration before any
attempt to implement a systematic screening programme
is made.
The first relates to the successful recruitment of south
Asian populations in screening programmes. In general,
previous studies have shown that interventions targeted
towards the general population often do not reach non-
Western ethnic minorities or appear to be less effective in
these populations [16, 17]. In the ADDITION-Leicester
study, the investigators tried to make the recruitment
process culturally sensitive by using appropriate promo-
tions, publicity and screening locations. Nevertheless, the
response to the invitation for screening was low among the
south Asian population, suggesting that the content of the
intervention should perhaps be further adapted or that
different methods of recruitment should be used depending
on the ethic group being targeted. For example, in a study
we found that, besides culturally adapting the materials
used, personal contact in the form of telephone reminders
instead of written reminders greatly enhanced participation
(I. G. M. van V alkengoed, K. Stronks, unpublished results).
In addition, one might hypothesise that screening for
diabetes by measuring the fasting plasma glucose level
and HbA1c might be more attractive to potential participants
than screening using an OGTT and therefore produce a
higher response. In this respect, it should be mentioned that
two trials aimed at evaluating the effect of a culturally
targeted lifestyle intervention among populations of south
Asian origin are under way that will be able to report on the
effect of targeted strategies for OGTT-based and non-
OGTT-based screening of type 2 diabetes and impaired
glucose regulation [11, 12].
Second, the health gain achieved after a successful
screening programme will depend on the availability of
an effective intervention. Many available interventions
h a v en o tb e e nt a r g e t e dt oa n de v a l u a t e da m o n gm i g r a n t
populations [18, 19]. Developing and evaluating targeted
interventions is of the utmost importance as ethnic differ-
ences in the effectiveness of interventions have been
reported previously. A well known example is the
difference in the effectiveness of drug treatment for
hypertension among African origin vs white European
origin populations [20].
Third, there is clear lack of information about the risk of
diabetes-related morbidity among south Asian populations.
Prospective research into the risk of disease among south
Asians with various degrees of glucose abnormality is
necessary in all age groups. Depending on this risk
assessment, the criteria for screening may have to be
adapted (e.g. age may have to be lowered) for this
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available to a larger number of people (e.g. to those with
impaired glucose regulation, not just those with type 2
diabetes).
Finally, we consider it important that these points are
investigated in different settings; that is, among south Asian
populations living in different European countries. The
different experiences and the variation in contexts will
likely provide valuable insights for further refining the
design and will take screening one step closer towards
implementation.
To summarise, Webb et al. confirm the potentially large
public health impact of screening for type 2 diabetes
mellitus in south Asians. Their study also makes clear,
however, that a number of issues have to be addressed
before this impact can actually be realised. Both from a
public health and a financial perspective, further research in
various settings on these issues is warranted. However,
even though we may still be one step away from the
implementation of targeted screening we should ensure that
the lack of evidence is not used as an excuse to withhold
interventions from those identified through regular medical
practice.
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